Can eczema be a marker for interal malignancy?

Skip to the main content

Liječnički vjesnik, Vol. 142 No. Supp 5, 2020.

Meeting abstract

https://doi.org/10.26800/LV-142-supp5-1

Can eczema be a marker for interal malignancy?

Ana Gašić ; School of Medicine, University of Zagreb, Zagreb, Croatia
Ivana Karla Franić ; School of Medicine, University of Zagreb, Zagreb, Croatia 2
Ana Giljanović ; School of Medicine, University of Zagreb, Zagreb, Croatia 2
Liborija Lugović Mihić ; Clinical Department of Dermatovenereology, Sestre Milosrdnice University Hospital Centre, Zagreb, Croatia

Full text: english pdf 178 Kb

downloads: 148

APA 6th Edition

Gašić, A., Franić, I.K., Giljanović, A. & Lugović Mihić, L. (2020). Can eczema be a marker for interal malignancy?. Liječnički vjesnik, 142 (Supp 5), 0-0. https://doi.org/10.26800/LV-142-supp5-1

MLA 8th Edition

Gašić, Ana, et al. "Can eczema be a marker for interal malignancy?." Liječnički vjesnik, vol. 142, no. Supp 5, 2020, pp. 0-0. https://doi.org/10.26800/LV-142-supp5-1. Accessed 4 May 2024.

Chicago 17th Edition

Gašić, Ana, Ivana Karla Franić, Ana Giljanović and Liborija Lugović Mihić. "Can eczema be a marker for interal malignancy?." Liječnički vjesnik 142, no. Supp 5 (2020): 0-0. https://doi.org/10.26800/LV-142-supp5-1

Harvard

Gašić, A., et al. (2020). 'Can eczema be a marker for interal malignancy?', Liječnički vjesnik, 142(Supp 5), pp. 0-0. https://doi.org/10.26800/LV-142-supp5-1

Vancouver

Gašić A, Franić IK, Giljanović A, Lugović Mihić L. Can eczema be a marker for interal malignancy?. Liječnički vjesnik [Internet]. 2020 [cited 2024 May 04];142(Supp 5). https://doi.org/10.26800/LV-142-supp5-1

IEEE

A. Gašić, I.K. Franić, A. Giljanović and L. Lugović Mihić, "Can eczema be a marker for interal malignancy?", Liječnički vjesnik, vol.142, no. Supp 5, pp. 0-0, 2020. [Online]. https://doi.org/10.26800/LV-142-supp5-1

Abstract

Paraneoplastic disorders are a group of uncommon symptoms assumed to occur due to the substances released by the tumour or due to abnormal immune system response in patients with internal malignancy. Some neoplastic diseases may present with various cutaneous manifestations.
Although these dermatoses are relatively rare, their identification can contribute to earlier diagnosis and a better outcome.

Keywords

immunosuppressants; internal malignancy; paraneoplastic disorder

Hrčak ID:

251231

URI

https://hrcak.srce.hr/251231

Publication date:

27.1.2021.

Visits: 465 *